The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on Q6I9R7
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Gene Ontology (GO) Annotations with Structured Vocabulary
Molecular Function: GO:0000900 translation repressor activity, nucleic acid binding GO:0000977 RNA polymerase II regulatory region sequence-specific DNA binding GO:0001012 RNA polymerase II regulatory region DNA binding GO:0003677 DNA binding GO:0003700 transcription factor activity, sequence-specific DNA binding GO:0003707 steroid hormone receptor activity GO:0003708 retinoic acid receptor activity GO:0004879 RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding GO:0008134 transcription factor binding GO:0008144 drug binding GO:0008270 zinc ion binding GO:0042826 histone deacetylase binding GO:0043565 sequence-specific DNA binding GO:0044212 transcription regulatory region DNA binding GO:0046872 metal ion binding GO:0048027 mRNA 5'-UTR binding
Biological Process: GO:0000122 negative regulation of transcription from RNA polymerase II promoter GO:0001657 ureteric bud development GO:0001843 neural tube closure GO:0001889 liver development GO:0002068 glandular epithelial cell development GO:0003148 outflow tract septum morphogenesis GO:0003417 growth plate cartilage development GO:0006351 transcription, DNA-templated GO:0006355 regulation of transcription, DNA-templated GO:0007281 germ cell development GO:0007283 spermatogenesis GO:0007565 female pregnancy GO:0008284 positive regulation of cell proliferation GO:0008285 negative regulation of cell proliferation GO:0008584 male gonad development GO:0010628 positive regulation of gene expression GO:0010629 negative regulation of gene expression GO:0017148 negative regulation of translation GO:0021766 hippocampus development GO:0030850 prostate gland development GO:0030852 regulation of granulocyte differentiation GO:0031076 embryonic camera-type eye development GO:0031641 regulation of myelination GO:0032355 response to estradiol GO:0032526 response to retinoic acid GO:0033189 response to vitamin A GO:0034097 response to cytokine GO:0035264 multicellular organism growth GO:0042981 regulation of apoptotic process GO:0043066 negative regulation of apoptotic process GO:0043401 steroid hormone mediated signaling pathway GO:0045471 response to ethanol GO:0045596 negative regulation of cell differentiation GO:0045666 positive regulation of neuron differentiation GO:0045892 negative regulation of transcription, DNA-templated GO:0045944 positive regulation of transcription from RNA polymerase II promoter GO:0045947 negative regulation of translational initiation GO:0048167 regulation of synaptic plasticity GO:0048384 retinoic acid receptor signaling pathway GO:0055012 ventricular cardiac muscle cell differentiation GO:0060010 Sertoli cell fate commitment GO:0060173 limb development GO:0060324 face development GO:0060348 bone development GO:0060534 trachea cartilage development GO:0060591 chondroblast differentiation GO:0061037 negative regulation of cartilage development GO:0071222 cellular response to lipopolysaccharide
DQ893531 - Synthetic construct clone IMAGE:100006161; FLH164152.01X; RZPDo839D03162D retinoic acid receptor, alpha (RARA) gene, encodes complete protein. BC008727 - Homo sapiens retinoic acid receptor, alpha, mRNA (cDNA clone MGC:1651 IMAGE:3163891), complete cds. AK312564 - Homo sapiens cDNA, FLJ92939, Homo sapiens retinoic acid receptor, alpha (RARA), mRNA. AK292205 - Homo sapiens cDNA FLJ78006 complete cds, highly similar to Homo sapiens retinoic acid receptor, alpha, mRNA. FJ487576 - Homo sapiens retinoic acid receptor alpha isoform 1 deltaBC (RARA) mRNA, complete cds, alternatively spliced. AK130192 - Homo sapiens cDNA FLJ26682 fis, clone MPG04930, highly similar to Retinoic acid receptor alpha (RAR-alpha). DL491558 - Novel nucleic acids. DL490160 - Novel nucleic acids. X06614 - Human mRNA for receptor of retinoic acid. JD190848 - Sequence 171872 from Patent EP1572962. JD530318 - Sequence 511342 from Patent EP1572962. JD115521 - Sequence 96545 from Patent EP1572962. CU679063 - Synthetic construct Homo sapiens gateway clone IMAGE:100019512 5' read RARA mRNA. KJ891981 - Synthetic construct Homo sapiens clone ccsbBroadEn_01375 RARA gene, encodes complete protein. AB590379 - Synthetic construct DNA, clone: pFN21AE1591, Homo sapiens RARA gene for retinoic acid receptor, alpha, without stop codon, in Flexi system. DQ893744 - Synthetic construct Homo sapiens clone IMAGE:100008204; FLH164148.01L; RZPDo839D03161D retinoic acid receptor, alpha (RARA) gene, encodes complete protein. CR457438 - Homo sapiens full open reading frame cDNA clone RZPDo834D086D for gene RARA, retinoic acid receptor, alpha; complete cds, incl. stopcodon. HQ692826 - Homo sapiens retinoic acid nuclear receptor alpha variant 1 (NR1B1) mRNA, complete cds. AF242867 - Synthetic construct ECFP-retinoic acid receptor alpha fusion protein mRNA, complete cds. X06538 - Human mRNA for retinoic acid receptor. AK098172 - Homo sapiens cDNA FLJ40853 fis, clone TRACH2015486, highly similar to RETINOIC ACID RECEPTOR ALPHA. AK303868 - Homo sapiens cDNA FLJ61038 complete cds, highly similar to Homo sapiens retinoic acid receptor, alpha (RARA), transcript variant 2, mRNA. AL834159 - Homo sapiens mRNA; cDNA DKFZp761C0417 (from clone DKFZp761C0417). BC071733 - Homo sapiens retinoic acid receptor, alpha, mRNA (cDNA clone MGC:88071 IMAGE:5217484), complete cds. CU687150 - Synthetic construct Homo sapiens gateway clone IMAGE:100022820 5' read RARA mRNA. HQ692827 - Homo sapiens retinoic acid nuclear receptor alpha variant 2 (NR1B1) mRNA, complete cds. KJ905891 - Synthetic construct Homo sapiens clone ccsbBroadEn_15561 RARA gene, encodes complete protein. AJ417079 - Homo sapiens partial mRNA for PML/RARA fusion protein (PML/RARA gene). AF012304 - Homo sapiens nuclear mitotic apparatus protein-retinoic acid receptor alpha fusion protein (NuMA-RARA fusion) mRNA, partial cds. KP100665 - Homo sapiens GTF2I-RARA fusion protein (GTF2I-RARA) mRNA, complete cds. U41743 - Human nucleophosmin-retinoic acid receptor alpha fusion protein NPM-RAR short form mRNA, complete cds. S50916 - PML-RAR fusion gene {fusion transcript} [human, mRNA Partial, 1284 nt]. U41742 - Human nucleophosmin-retinoic acid receptor alpha fusion protein NPM-RAR long form mRNA, complete cds. M73779 - Human PML-RAR protein (PML-RAR) mRNA, complete cds. X63645 - H.sapiens PML-RAR alpha-bcr1-2 gene. EF535849 - Homo sapiens PML/RARA fusion mRNA, partial sequence. X58685 - Human mRNA for retinoic acid receptor-alpha, exon 3. KF589333 - Homo sapiens TBLR1-RARA fusion protein (TBLR1-RARA fusion) mRNA, complete cds. AF242868 - Synthetic construct ECFP-retinoic acid receptor ligand binding domain fusion protein mRNA, complete cds. JD098295 - Sequence 79319 from Patent EP1572962. JD202419 - Sequence 183443 from Patent EP1572962. JD261105 - Sequence 242129 from Patent EP1572962. JD190924 - Sequence 171948 from Patent EP1572962. JD071572 - Sequence 52596 from Patent EP1572962. JD368863 - Sequence 349887 from Patent EP1572962. JD477489 - Sequence 458513 from Patent EP1572962. JD210822 - Sequence 191846 from Patent EP1572962. JD346858 - Sequence 327882 from Patent EP1572962. JD227278 - Sequence 208302 from Patent EP1572962. JD233566 - Sequence 214590 from Patent EP1572962. JD528691 - Sequence 509715 from Patent EP1572962. JD413988 - Sequence 395012 from Patent EP1572962. JD541030 - Sequence 522054 from Patent EP1572962. JD485394 - Sequence 466418 from Patent EP1572962. JD122404 - Sequence 103428 from Patent EP1572962. JD385427 - Sequence 366451 from Patent EP1572962. JD076083 - Sequence 57107 from Patent EP1572962. JD415442 - Sequence 396466 from Patent EP1572962. JD062457 - Sequence 43481 from Patent EP1572962. JD458297 - Sequence 439321 from Patent EP1572962. JD383555 - Sequence 364579 from Patent EP1572962. JD341660 - Sequence 322684 from Patent EP1572962. JD431701 - Sequence 412725 from Patent EP1572962. JD216613 - Sequence 197637 from Patent EP1572962. JD103324 - Sequence 84348 from Patent EP1572962. JD115531 - Sequence 96555 from Patent EP1572962. JD110495 - Sequence 91519 from Patent EP1572962. JD052784 - Sequence 33808 from Patent EP1572962. JD157694 - Sequence 138718 from Patent EP1572962. JD253907 - Sequence 234931 from Patent EP1572962. JD120760 - Sequence 101784 from Patent EP1572962. JD219738 - Sequence 200762 from Patent EP1572962. JD054897 - Sequence 35921 from Patent EP1572962. JD322063 - Sequence 303087 from Patent EP1572962.
Biochemical and Signaling Pathways
BioCarta from NCI Cancer Genome Anatomy Project h_egfr_smrtePathway - Map Kinase Inactivation of SMRT Corepressor h_nuclearRsPathway - Nuclear Receptors in Lipid Metabolism and Toxicity h_carm1Pathway - Transcription Regulation by Methyltransferase of CARM1 h_rarPathway - Degradation of the RAR and RXR by the proteasome h_pmlPathway - Regulation of transcriptional activity by PML h_rarrxrPathway - Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells